L
Laicuinuo LCN
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | B | 7 | 8.0 | 5.2 | 10.0 | 30 Sep 2025 |
| 5-amino-1MQ | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| AHK-CU | X | 1 | 6.7 | 6.7 | 6.7 | 2 Jul 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 |
| Cardiogen | X | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 |
| Cartalax | X | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 |
| Cerebrolysin | X | 1 | 8.5 | 8.5 | 8.5 | 28 Mar 2025 |
| Chonluten | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 |
| DHB (1-Test Cyp) Oral | X | 1 | 7.8 | 7.8 | 7.8 | 6 May 2025 |
| DHB (1-Test Cyp) | X | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 |
| Dianabol Raw | X | 1 | 8.5 | 8.5 | 8.5 | 25 Apr 2025 |
| DSIP | X | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 |
| EPO | X | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 |
| Glutathione | X | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 |
| GW-501516 (Cardarine) | X | 1 | 8.9 | 8.9 | 8.9 | 3 Jul 2025 |
| HGH Fragment 176-191 | X | 1 | 6.3 | 6.3 | 6.3 | 21 May 2025 |
| IGF-1 LR3 | X | 1 | 5.8 | 5.8 | 5.8 | 14 Jan 2025 |
| KissPeptin-10 | X | 1 | 7.1 | 7.1 | 7.1 | 27 Feb 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 5.6 | 5.6 | 5.6 | 25 Apr 2025 |
| LGD-4033 (Ligandrol) | X | 1 | 9.0 | 9.0 | 9.0 | 2 Apr 2025 |
| LL37 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 |
| Methylene Blue | X | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 |
| MOTS-C | X | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 |
| MT-1 | X | 1 | 8.4 | 8.4 | 8.4 | 2 Jul 2025 |
| NAD+ Injectable | X | 1 | 6.1 | 6.1 | 6.1 | 25 Apr 2025 |
| Orforglipron | X | 1 | 9.1 | 9.1 | 9.1 | 11 Jun 2025 |
| Prostamax | X | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 |
| Semaglutide Raw | X | 1 | 8.2 | 8.2 | 8.2 | 24 Apr 2025 |
| T3 (Liothyronine) | X | 1 | 8.2 | 8.2 | 8.2 | 8 Jul 2025 |
| Thymalin | X | 1 | 6.0 | 6.0 | 6.0 | 3 Jul 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | Glutathione | 9.2 | 50mg | 46.2mg | -7.6% | 97.84% | Lab E |
| 24 May 2026 | 5-amino-1MQ | 10.0 | 30mg | 26.7mg | -10.9% | 98.21% | Lab D |
| 24 May 2026 | Prostamax | 7.9 | 10mg | 10.4mg | +3.9% | 97.76% | Lab F |
| 24 May 2026 | Thymalin | 5.6 | 30mg | 35.1mg | +17.1% | 95.45% | Lab A |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.1 | 10mg | 9.7mg | -3.2% | 97.54% | Lab E |
| 23 May 2026 | Methylene Blue | 6.8 | 100mg | 110.9mg | +10.9% | 99.53% | Lab C |
| 23 May 2026 | DSIP | 9.7 | 2mg | 2.4mg | +20.6% | 98.83% | Lab G |
| 21 May 2026 | EPO | 6.9 | 15mg | 15.5mg | +3.2% | 96.39% | Lab D |
| 21 May 2026 | LGD-4033 (Ligandrol) | 9.4 | 50mg | 57.6mg | +15.2% | 97.66% | Lab B |
| 20 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 9.7 | 20mg | 23.1mg | +15.4% | 99.81% | Lab F |
| 17 May 2026 | MOTS-C | 9.6 | 20mg | 22.1mg | +10.7% | 97.78% | Lab D |
| 17 May 2026 | NAD+ Injectable | 6.5 | 100mg/ml | 108.8mg/ml | +8.8% | 99.13% | Lab D |
| 29 Jan 2026 | DHB (1-Test Cyp) | 9.3 | 100mg/ml | 108.1mg/ml | +8.1% | 96.68% | Lab C |
| 26 Jan 2026 | Selank 10mg + Semax 10mg Blend | 8.6 | 10mg | 9.0mg | -10.3% | 95.34% | Lab G |
| 26 Jan 2026 | Semaglutide Raw | 9.3 | 500g | 453.5g | -9.3% | 99.54% | Lab A |
| 19 Jan 2026 | Cerebrolysin | 10.0 | 10mg | 12.0mg | +19.8% | 95.26% | Lab A |
| 9 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.3 | 100g | 101.9g | +1.9% | 98.02% | Lab A |
| 9 Jan 2026 | HGH Fragment 176-191 | 7.2 | 10mg | 11.6mg | +15.5% | 98.50% | Lab E |
| 7 Jan 2026 | Tirzepatide | 8.4 | 20mg | (no batch claim) | 21.7mg | +8.5% | White Label / Silver Crimp / Violet Cap |
| 7 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.5 | 20mg | 24.8mg | +23.8% | 97.13% | Lab E |
| 6 Jan 2026 | Dianabol Raw | 9.9 | 100g | 91.1g | -8.9% | 95.11% | Lab A |
| 6 Jan 2026 | T3 (Liothyronine) | 10.0 | 50mg | 49.4mg | -1.1% | 97.41% | Lab B |
| 29 Dec 2025 | Cartalax | 8.9 | 2mg | 2.1mg | +5.3% | 96.78% | Lab G |
| 12 Dec 2025 | AHK-CU | 8.1 | 30mg | 37.5mg | +25.0% | 97.19% | Lab G |
| 6 Dec 2025 | Tirzepatide | 6.3 | 20mg | (no batch claim) | 34.6mg | +73.0% | White Label / Silver Crimp / Violet Cap |
| 5 Dec 2025 | Cardiogen | 7.5 | 5mg | 5.5mg | +9.9% | 95.94% | Lab D |
| 5 Dec 2025 | IGF-1 LR3 | 6.0 | 15mg | 16.9mg | +12.9% | 95.71% | Lab F |
| 5 Dec 2025 | LL37 | 5.0 | 30mg | 28.1mg | -6.4% | 98.55% | Lab G |
| 17 Nov 2025 | GW-501516 (Cardarine) | 10.0 | 20mg | 19.2mg | -4.0% | 98.44% | Lab A |
| 14 Nov 2025 | Orforglipron | 9.0 | 25mg | 30.4mg | +21.8% | 98.02% | Lab B |
| 5 Nov 2025 | DHB (1-Test Cyp) Oral | 7.8 | 20mg | 18.3mg | -8.3% | 96.03% | Lab B |
| 4 Nov 2025 | Chonluten | 9.9 | 30mg | 31.4mg | +4.7% | 96.42% | Lab G |
| 4 Nov 2025 | KissPeptin-10 | 6.9 | 2mg | 1.8mg | -10.1% | 97.92% | Lab A |
| 24 Oct 2025 | Tirzepatide | 7.1 | 30mg | (no batch claim) | 32.09mg | +7.0% | No Label / Silver Crimp / Pink Cap |
| 24 Oct 2025 | Tirzepatide | 5.2 | 5mg | 6.4mg | 4.98mg | -22.1% | (no data) |
| 23 Oct 2025 | Tirzepatide | 10.0 | 30mg | (no batch claim) | 30.6mg | +2.0% | No Label / Silver Crimp / Pink Cap |
| 9 Oct 2025 | MT-1 | 9.7 | 30mg | 26.7mg | -10.9% | 98.55% | Lab A |
| 3 Oct 2025 | Tirzepatide | 9.8 | 10mg | (no batch claim) | 10mg | White Label / Silver Crimp / Yellow Cap | |
| 30 Sep 2025 | Tirzepatide | 9.5 | 30mg | 30.6mgpackage | 29.8mg | -2.7% | No Label / Silver Crimp / Violet Cap |